JP2022519696A5 - - Google Patents
Info
- Publication number
- JP2022519696A5 JP2022519696A5 JP2021546005A JP2021546005A JP2022519696A5 JP 2022519696 A5 JP2022519696 A5 JP 2022519696A5 JP 2021546005 A JP2021546005 A JP 2021546005A JP 2021546005 A JP2021546005 A JP 2021546005A JP 2022519696 A5 JP2022519696 A5 JP 2022519696A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- solvate
- acceptable salt
- alkyl
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962802642P | 2019-02-07 | 2019-02-07 | |
| US62/802,642 | 2019-02-07 | ||
| PCT/US2020/017314 WO2020163778A1 (en) | 2019-02-07 | 2020-02-07 | Tyk2 pseudokinase ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022519696A JP2022519696A (ja) | 2022-03-24 |
| JP2022519696A5 true JP2022519696A5 (https=) | 2023-02-15 |
Family
ID=71947508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546005A Pending JP2022519696A (ja) | 2019-02-07 | 2020-02-07 | Ｔｙｋ２偽キナーゼリガンド |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220135567A1 (https=) |
| EP (1) | EP3920931A4 (https=) |
| JP (1) | JP2022519696A (https=) |
| KR (1) | KR20210124409A (https=) |
| CN (1) | CN113677347A (https=) |
| AU (1) | AU2020218267A1 (https=) |
| BR (1) | BR112021015616A2 (https=) |
| CA (1) | CA3129438A1 (https=) |
| IL (1) | IL285429A (https=) |
| MX (1) | MX2021009555A (https=) |
| SG (1) | SG11202108619SA (https=) |
| WO (1) | WO2020163778A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7631193B2 (ja) | 2018-10-22 | 2025-02-18 | アルミス インコーポレイテッド | Ｔｙｋ２阻害剤およびその使用 |
| CA3134814A1 (en) | 2019-03-26 | 2020-10-01 | Ventyx Biosciences, Inc. | Tyk2 pseudokinase ligands |
| JP7635228B2 (ja) | 2019-11-08 | 2025-02-25 | ベンティックス バイオサイエンシーズ，インク． | Ｔｙｋ２偽キナーゼリガンド |
| EP4214215A1 (en) * | 2020-09-16 | 2023-07-26 | Alumis Inc. | Tyk2 inhibitors and uses thereof |
| WO2022156657A1 (en) * | 2021-01-19 | 2022-07-28 | Anrui Biomedical Technology (Guangzhou) Co., Ltd. | Imidazolopyridazine or pyrazolopyrimidine compounds and compositions |
| EP4423086A1 (en) | 2021-10-25 | 2024-09-04 | Kymera Therapeutics, Inc. | Tyk2 degraders and uses thereof |
| WO2025061180A1 (zh) * | 2023-09-22 | 2025-03-27 | 杭州多域生物技术有限公司 | 含氮并环类化合物、其药物组合物及其应用 |
| WO2025165746A1 (en) * | 2024-01-30 | 2025-08-07 | Ennovathera, Inc. | Certain chemical entities, compositions, and methods |
| WO2025168035A1 (zh) * | 2024-02-07 | 2025-08-14 | 合肥羿科医药有限公司 | 杂环类化合物、其药物组合物及其应用 |
| WO2025214467A1 (zh) * | 2024-04-12 | 2025-10-16 | 江苏恒瑞医药股份有限公司 | 氨基取代的杂芳环类化合物、其制备方法及其在医药上的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7557110B2 (en) * | 2003-02-28 | 2009-07-07 | Teijin Pharma Limited | Pyrazolo[1,5-A] pyrimidine derivatives |
| EP2348860B1 (en) * | 2008-10-31 | 2015-05-27 | Genentech, Inc. | Pyrazolopyrimidine jak inhibitor compounds and methods |
| US10479793B2 (en) * | 2015-11-18 | 2019-11-19 | Bristol-Myers Squibb Company | Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses |
| TW201720828A (zh) * | 2015-11-23 | 2017-06-16 | 赫孚孟拉羅股份公司 | 治療性化合物及組合物以及其使用方法 |
| TW202515876A (zh) * | 2017-03-08 | 2025-04-16 | 日商武田藥品工業股份有限公司 | Tyk2抑制劑及其用途 |
| CN110678467B (zh) * | 2017-05-22 | 2023-06-13 | 豪夫迈·罗氏有限公司 | 治疗化合物和组合物及其使用方法 |
| SI3658557T1 (sl) * | 2017-07-28 | 2024-10-30 | Takeda Pharmaceutical Company Limited | Zaviralci TYK2 in njihova uporaba |
| JP7179161B2 (ja) * | 2018-09-10 | 2022-11-28 | イーライ リリー アンド カンパニー | 乾癬および全身性エリテマトーデスの処置に有用なピラゾロ［１，５－ａ］ピリミジン－３－カルボキサミド誘導体 |
| CN113271940A (zh) * | 2018-10-15 | 2021-08-17 | 林伯士拉克许米公司 | Tyk2抑制剂和其用途 |
| AR117177A1 (es) * | 2018-12-10 | 2021-07-14 | Lilly Co Eli | DERIVADOS DE 7-(METILAMINO)PIRAZOLO[1,5-A]PIRIMIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE IL-23 E INFa |
| JP7635228B2 (ja) * | 2019-11-08 | 2025-02-25 | ベンティックス バイオサイエンシーズ，インク． | Ｔｙｋ２偽キナーゼリガンド |
-
2020
- 2020-02-07 JP JP2021546005A patent/JP2022519696A/ja active Pending
- 2020-02-07 BR BR112021015616A patent/BR112021015616A2/pt not_active Application Discontinuation
- 2020-02-07 CN CN202080026979.3A patent/CN113677347A/zh active Pending
- 2020-02-07 AU AU2020218267A patent/AU2020218267A1/en not_active Abandoned
- 2020-02-07 KR KR1020217028660A patent/KR20210124409A/ko not_active Ceased
- 2020-02-07 WO PCT/US2020/017314 patent/WO2020163778A1/en not_active Ceased
- 2020-02-07 SG SG11202108619SA patent/SG11202108619SA/en unknown
- 2020-02-07 US US17/428,953 patent/US20220135567A1/en not_active Abandoned
- 2020-02-07 MX MX2021009555A patent/MX2021009555A/es unknown
- 2020-02-07 CA CA3129438A patent/CA3129438A1/en active Pending
- 2020-02-07 EP EP20752194.9A patent/EP3920931A4/en not_active Withdrawn
-
2021
- 2021-08-08 IL IL285429A patent/IL285429A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022519696A5 (https=) | ||
| JP2022529311A5 (https=) | ||
| JP2022553841A5 (https=) | ||
| JP2024520481A5 (https=) | ||
| RU2318816C2 (ru) | 4-замещенные имидазол-2-тионы и имидазол-2-оны в качестве агонистов альфа2b- и альфа2c- адренергических рецепторов | |
| JP2023518044A5 (https=) | ||
| JP2022532877A5 (https=) | ||
| JP2024543512A5 (https=) | ||
| JP2020500178A5 (https=) | ||
| JP2023553835A5 (https=) | ||
| JP2024529839A5 (https=) | ||
| JP2019531279A5 (https=) | ||
| JP2021522262A5 (https=) | ||
| JP2022547617A5 (https=) | ||
| JP2024167182A5 (https=) | ||
| JP2012526728A5 (https=) | ||
| JP2022550640A5 (https=) | ||
| JP2017504576A5 (https=) | ||
| JP2018504437A5 (https=) | ||
| JP2022538917A5 (https=) | ||
| JP2020529994A5 (https=) | ||
| IL292785B2 (en) | Tyk2 pseudokinase ligands | |
| JP2019535813A5 (https=) | ||
| JP2022552445A5 (https=) | ||
| JP2025502943A5 (https=) |